Your NEJM Group Today: Discussion: Rivaroxaban or Aspirin? / Quinine & Mortality / Massachusetts Primary Care Opportunities (FREE)

By the Editors Here ' s what we chose for you from NEJM Group today:NEJM Resident 360: Journal Club: The authors of the recent NEJM article, " Rivaroxaban or Aspirin …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Aspirin | Primary Care